LitAlert ~~

    • The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer.
    • Chen L, Fu F, Huang M, Lv J, Zhang W, Wang C.
    • Breast Cancer Res Treat. 2020 Feb 18. doi: 10.1007/s10549-020-05573-x. [Epub ahead of print]
    • Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer.
    • Wong EM, Southey MC, Terry MB.
    • Br J Cancer. 2020 Feb 18. doi: 10.1038/s41416-019-0720-2. [Epub ahead of print]